EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A correctable immune niche for epithelial stem cell reprogramming and post-viral lung diseases

Kangyun Wu, Yong Zhang, Huiqing Yin-DeClue, Kelly Sun, Dailing Mao, Kuangying Yang, Stephen R Austin, Erika C Crouch, Steven L Brody, Derek E Byers, Christy M Hoffmann, Michael E Hughes und 1 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci183092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Kangyun Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary and Critical Care Medicine, Department of Medicine. Hauptthemen laut MEDLINE: Cellular Reprogramming. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Department of Defense, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial barriers are programmed for defense and repair but are also the site of long-term structural remodeling and disease. In general, this paradigm features epithelial stem cells (ESCs) that are called on to regenerate damaged tissues but can also be reprogrammed for detrimental remodeling. Here we identified a Wfdc21- dependent monocyte-derived dendritic cell (moDC) population that functioned as an early sentinel niche for basal ESC reprogramming in mouse models of epithelial injury after respiratory viral infection. Niche function depended on moDC delivery of ligand GPNMB to the basal ESC receptor CD44 so that properly timed antibody blockade of ligand or receptor provided long-lasting correction of reprogramming and broad disease phenotypes. These same control points worked directly in mouse and human basal ESC organoids. Together, the findings identify a mechanism to explain and modify what is otherwise a stereotyped but sometimes detrimental response to epithelial injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular ReprogrammingAnimalsMiceHumansEpithelial CellsDendritic CellsHyaluronan ReceptorsMembrane GlycoproteinsStem Cell NicheStem CellsLung Diseases

Stichwörter der Autor:innen

Adult stem cellsInfluenzaPulmonologyRespiration

Substanzen

Hyaluronan ReceptorsMembrane GlycoproteinsCd44 protein, mouseCD44 protein, human

Autor:innen und Institutionen

  • Pulmonary and Critical Care Medicine, Department of Medicine.
  • Department of Pathology and Immunology.
  • Department of Genetics, and.
  • Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, USA.

Förderung

  • NHLBI NIH HHS
  • Department of Defense
  • National Institutes of Health

Zitieren

APA

Wu, K., Zhang, Y., Yin-DeClue, H., Sun, K., Mao, D., Yang, K., Austin, S. R., Crouch, E. C., Brody, S. L., Byers, D. E., Hoffmann, C. M., Hughes, M. E., & Holtzman, M. J. (2024). A correctable immune niche for epithelial stem cell reprogramming and post-viral lung diseases. Journal of Clinical Investigation. https://doi.org/10.1172/jci183092

Vancouver

Wu K, Zhang Y, Yin-DeClue H, Sun K, Mao D, Yang K, et al. A correctable immune niche for epithelial stem cell reprogramming and post-viral lung diseases. Journal of Clinical Investigation. 2024. doi:10.1172/jci183092

BibTeX
@article{Wu2024,
  author = {Wu, Kangyun and Zhang, Yong and Yin-DeClue, Huiqing and Sun, Kelly and Mao, Dailing and Yang, Kuangying and Austin, Stephen R and Crouch, Erika C and Brody, Steven L and Byers, Derek E and Hoffmann, Christy M and Hughes, Michael E and Holtzman, Michael J},
  title = {A correctable immune niche for epithelial stem cell reprogramming and post-viral lung diseases},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci183092}
}
Kostenlos starten →